ACLX
Arcellx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$115.07
+0.02%Leverage
- Debt / equity
- 0.24x
- Net debt / equity
- 0.04x
- Debt / assets
- 0.16x
- Debt / EBITDA
- -0.49x
- Net debt / EBITDA
- -0.08x
Liquidity & coverage
- Current ratio
- 4.44x
- Quick ratio
- 4.44x
- Cash ratio
- 4.32x
- Interest coverage
- -10.45x
- EBITDA / interest
- -8.17x
- Working capital
- $358.0M
Cash & dividend
- FCF / debt
- -2.21x
- Cash flow / debt
- -2.18x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025